Overexpression of human ortholog of mammalian enabled (hMena) is associated with the expression of mutant p53 protein in human breast cancers

International Journal of Oncology

Volumn 38, Issue 1, 2011, Pages 89-96

  Toyoda, Akihiro ^a   Yokota, Aya ^a,b   Saito, Teruyoshi ^a   Kawana, Hidetada ^a,c   Higashi, Morihiro ^a,d   Suzuki, Yoshio ^b   Tanaka, Tomoaki ^a   Kitagawa, Motoo ^a   Harigaya, Kenichi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Asahi Central Hospital   (Japan)

^c CHIBA CANCER CENTER   (Japan)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Breast; Ena VASP; hMena; Infiltrating ductal carcinoma; p53

Indexed keywords

COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; KI 67 ANTIGEN; PHOSPHOPROTEIN; PROTEIN HMENA; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; DOWN REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR VOLUME;

BREAST NEOPLASMS; CARCINOMA, DUCTAL; DISEASE PROGRESSION; DNA, COMPLEMENTARY; DOWN-REGULATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; GENES, P53; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MICROFILAMENT PROTEINS; PROGNOSIS; RECEPTOR, ERBB-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78650847291     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-00000827     Document Type: Article

References (28)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008.
2. The Japanese Breast Cancer Society: Morbidity of breast cancers in Japanese women. Kanehara Shuppan, Tokyo, 2008.
3. Janicke F, Schmitt M, Pache L, Ulm K, Harbeck N, Hofler H and Graeff H: Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer. Breast Cancer Res Treat 24: 195-208, 1993. (Pubitemid 23062819)
4. Ostrowski JL, Sawan A, Henry L, et al: p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study. J Pathol 164: 75-81, 1991.
5. Porter PL, Malone KE, Heagerty PJ, et al: Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3: 222-225, 1997.
6. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182, 1987.
7. Wiesner FG, Magener A, Fasching PA, et al: Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patients. Breast 18: 135-141, 2009.
8. Muller A, Homey B, Soto H, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001.
9. Van de Vijver MJ, He YD, van't Veer LJ, et al: A geneexpression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009, 2002.
10. Van't Veer LJ, Dai H, van de Vijver MJ, et al: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536, 2002.
11. Friedl P and Wolf K: Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3: 362-374, 2003. (Pubitemid 37328856)
12. Krause M, Dent EW, Bear JE, Loureiro JJ and Gertler FB: Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration. Annu Rev Cell Dev Biol 19: 541-564, 2003.
13. + T-cell immune response. Int J Cancer 109: 909-918, 2004.
14. Di Modugno F, Mottolese M, Di Benedetto A, et al: The cytoskeleton regulatory protein hMena (ENAH) is overexpressed in human benign breast lesions with high risk of transformation and human epidermal growth factor receptor-2-positive/hormonal receptor-negative tumors. Clin Cancer Res 12: 1470-1478, 2006.
15. Toyoda A, Kawana H, Azuhata K, et al: Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression. Int J Oncol 34: 53-60, 2009.
16. Kingston RE, Chen CA and Rose JK: Calcium phosphate transfection. Curr Protoc Mol Biol Chapter 9: Unit 9.1, 2003.
17. Monney L, Sabatos CA, Gaglia JL, et al: Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415: 536-541, 2002.
18. Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV and Lane DP: p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87: 7555-7559, 1990.
19. Di Modugno F, DeMonte L, Balsamo M, et al: Molecular cloning of hMena (ENAH) and its splice variant hMena+11a: epidermal growth factor increases their expression and stimulates hMena+11a phosphorylation in breast cancer cell lines. Cancer Res 67: 2657-2665, 2007. (Pubitemid 46548953)
20. Scholzen T and Gerdes J: The Ki-67 protein: from the known and the unknown. J Cell Physiol 182: 311-322, 2000.
21. Philippar U, Roussos ET, Oser M, et al: A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis. Dev Cell 15: 813-828, 2008.
22. Goswami S, Philippar U, Sun D, et al: Identification of invasion specific splice variants of the cytoskeletal protein Mena present in mammary tumor cells during invasion in vivo. Clin Exp Metastasis 26: 153-159, 2009.
23. Coles C, Condie A, Chetty U, Steel CM, Evans HJ and Prosser J: p53 mutations in breast cancer. Cancer Res 52: 5291-5298, 1992.
24. Ginsberg D, Michael-Michalovitz D and Oren M: Induction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of the protein. Mol Cell Biol 11: 582-585, 1991.
25. Roger L, Gadea G and Roux P: Control of cell migration: a tumour suppressor function for p53? Biol Cell 98: 141-152, 2006.
26. Guo F and Zheng Y: Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion. Oncogene 23: 5577-5585, 2004.
27. Guo F and Zheng Y: Involvement of Rho family GTPases in p19Arf- and p53-mediated proliferation of primary mouse embryonic fibroblasts. Mol Cell Biol 24: 1426-1438, 2004. (Pubitemid 38112201)
28. Gadea G, Roger L, Anguille C, De Toledo M, Gire V and Roux P: TNFalpha induces sequential activation of Cdc42- and p38/p53-dependent pathways that antagonistically regulate filopodia formation. J Cell Sci 117: 6355-6364, 2004.